Search

Search Constraints

You searched for: Author/Creator Giovannoni, Gavin

Search Results

3. 015  Reduced risk of secondary progressive multiple sclerosis by treatment with clad- ribine tablets: CLARITY study analysis. Issue 6 (27th May 2022)

4. 016  Long-term disease stability in patients treated with cladribine tablets in CLARITY and CLARITY extension. Issue 6 (27th May 2022)

5. 018  Disease control beyond NEDA: the value of non-clinical measures to determine treatment response to natalizumab. Issue 6 (27th May 2022)

6. 020  Long-term efficacy of ocrelizumab in relapsing multiple sclerosis: 6 study years. Issue 6 (27th May 2022)

8. 022  Updated safety of cladribine tablets in multiple sclerosis patients: integrated safety analysis and post-approval data. Issue 6 (27th May 2022)

10. 033 Effect of ocrelizumab on upper limb function in patients with primary progressive multiple sclerosis (PPMS) in the oratorio study (ENCORE). Issue 6 (24th May 2018)